Ascendiant Capital Maintains Buy on Myomo, Raises Price Target to $10.5

Benzinga Newsdesk www.benzinga.com Positive 69.6%

Neg 0% Neu 0% Pos 69.6%

Ascendiant Capital analyst Edward Woo maintains Myomo (AMEX:MYO) with a Buy and raises the price target from $10 to $10.5.